Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
Chandrashekhar Athare, Associate Director at Innomagine Consulting Private Limited, shared a post on LinkedIn:
“As EHA 2026 comes to a close, I would like to express my gratitude to the organizers, speakers, exhibitors, and fellow attendees for an excellent congress in Stockholm.
Over the past few days, I had the opportunity to learn about the latest advancements in hematology, attend inspiring scientific sessions, and connect with professionals from across the global healthcare and life sciences community.
The insights gained, conversations shared, and connections made will undoubtedly contribute to future collaborations and continued learning.
A special thanks to everyone who took the time to connect and exchange ideas.
I look forward to staying in touch and continuing these discussions beyond the congress.
Until next time—looking forward to EHA 2027!”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments